Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-22.17%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-22.17%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-370.63%
Never
—
—
Never
—
5 Years
Score—
Net Growth-370.63%
Net TrendNever
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Immunovant Inc fundamental performance
Across Immunovant Inc's full reported history, from 2020 to 2026, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 66M to -$ 505M. Revenue increased in 0% of the years measured; net income in 0%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 42.60 | — |
1 Year2025-08-12 | $ 15.21 | 180.08% |
5 Years2021-08-12 | $ 8.14 | 423.34% |
All Time2019-06-21 | $ 9.95 | 328.14% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-06-21 |
|---|---|---|---|---|
| Price | $ 42.60 | $ 15.21 | $ 8.14 | $ 9.95 |
| Return | — | 180.08% | 423.34% | 328.14% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 505M | $ 902M |
| 2025 | $ 0.00 | -$ 413M | $ 713M |
| 2024 | $ 0.00 | -$ 259M | $ 635M |
| 2023 | $ 0.00 | -$ 210M | $ 376M |
| 2022 | $ 0.00 | -$ 156M | $ 493M |
| 2021 | $ 0.00 | -$ 107M | $ 400M |
| 2020 | $ 0.00 | -$ 66M | $ 100M |
Explore beyond IMVT
You're looking at Immunovant Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
